ORIGINAL PAPER<BR>Clinical application of CardioSEAL/STARFlex devices for transcatheter closure of atrial septal defect, patent foramen ovale and patent ductus arteriosus

Jacek Białkowski; Małgorzata Szkutnik; Jacek Kusa; Jacek Baranowski; Paweł Banaszak; Maria Żyła-Frycz; Piotr Kapik

eISSN: 1897-4295
ISSN: 1734-9338

Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2006
vol. 2

Send email

Copy url:

abstract:

ORIGINAL PAPER
Clinical application of CardioSEAL/STARFlex devices for transcatheter closure of atrial septal defect, patent foramen ovale and patent ductus arteriosus

Jacek Białkowski

,

Małgorzata Szkutnik

,

Jacek Kusa

,

Jacek Baranowski

,

Paweł Banaszak

,

Maria Żyła-Frycz

,

Piotr Kapik

Post Kardiol Interw 2006; 2, 1: 83-86

Online publish date: 2006/03/29

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Białkowski J, Szkutnik M, Kusa J, et al. ORIGINAL PAPERClinical application of CardioSEAL/STARFlex devices for transcatheter closure of atrial septal defect, patent foramen ovale and patent ductus arteriosus. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2006;2(1):83-86.

APA

Białkowski, J., Szkutnik, M., Kusa, J., Baranowski, J., Banaszak, P.,  & Żyła-Frycz, M. et al. (2006). ORIGINAL PAPERClinical application of CardioSEAL/STARFlex devices for transcatheter closure of atrial septal defect, patent foramen ovale and patent ductus arteriosus. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 2(1), 83-86.

Chicago

Białkowski, Jacek, Małgorzata Szkutnik, Jacek Kusa, Jacek Baranowski, Paweł Banaszak, Maria Żyła-Frycz,  and Piotr Kapik. 2006. "ORIGINAL PAPERClinical application of CardioSEAL/STARFlex devices for transcatheter closure of atrial septal defect, patent foramen ovale and patent ductus arteriosus". Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej 2 (1): 83-86.

Harvard

Białkowski, J., Szkutnik, M., Kusa, J., Baranowski, J., Banaszak, P., Żyła-Frycz, M.,  and Kapik, P. (2006). ORIGINAL PAPERClinical application of CardioSEAL/STARFlex devices for transcatheter closure of atrial septal defect, patent foramen ovale and patent ductus arteriosus. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 2(1), pp.83-86.

MLA

Białkowski, Jacek et al. "ORIGINAL PAPERClinical application of CardioSEAL/STARFlex devices for transcatheter closure of atrial septal defect, patent foramen ovale and patent ductus arteriosus." Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, vol. 2, no. 1, 2006, pp. 83-86.

Vancouver

Białkowski J, Szkutnik M, Kusa J, Baranowski J, Banaszak P, Żyła-Frycz M et al. ORIGINAL PAPERClinical application of CardioSEAL/STARFlex devices for transcatheter closure of atrial septal defect, patent foramen ovale and patent ductus arteriosus. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2006;2(1):83-86.

CardioSEAL/STARFlex devices (CS/SF) are double umbrella systems, which have several technical advantages such as: low profile, low nitinol content and relatively large covering surface. Our clinical experience with application of those devices is presented.
Material and methods: From 1999 till 2005 transcatheter closure of undesirable shunts with CS/SF was performed in 45 patients (pts). They were divided into 3 groups: – Atrial Septal Defect (ASD): 32 pts aged 12.3 (4 to 27) years; – Persistent Foramen Ovale (PFO): 10 pts aged 31.7 (13 to 54) years; – Patent Ductus Arteriosus (PDA): 3 pts aged 16, 17 and 62 years. Indications for CS/SF implantations were: – in ASD: small, centrally located defect or multifenestrated aneurysm of the interatrial septum (IAS); – in PFO: history of cryptogenic transient ischemic attacks or stroke and right to left shunt through short PFO tunnel (<8 mm) on Valsalva maneuver; – in PDA: large, window type duct. Standard transvenous technique of CS/SF implantation was applied in all pts.
Results: In all but 2 pts the procedures were completed successfully. The reason of 2 procedural failures during ASD closure was unsatisfactory umbrella position. Complete closure of undesirable communications was achieved in all but one pt with multiperforated aneurysm of IAS. In the latter pt the residual shunt was of no haemodynamic significance.
Conclusions: Transcatheter closure of some ASD, PDA and PFO with Cardioseal/Staflex umbrella can be the treatment of choice in a selected group of patients.

keywords:

ORIGINAL PAPERClinical application of CardioSEAL/STARFlex devices for transcatheter closure of atrial septal defect, patent foramen ovale and patent ductus arteriosus

Jacek Białkowski , Małgorzata Szkutnik , Jacek Kusa , Jacek Baranowski , Paweł Banaszak , Maria Żyła-Frycz , Piotr Kapik

interventional cathetrization, congenital heart defects, Starflex device

ORIGINAL PAPER
Clinical application of CardioSEAL/STARFlex devices for transcatheter closure of atrial septal defect, patent foramen ovale and patent ductus arteriosus

Jacek Białkowski

,

Małgorzata Szkutnik

,

Jacek Kusa

,

Jacek Baranowski

,

Paweł Banaszak

,

Maria Żyła-Frycz

,

Piotr Kapik